Table 1.

Baseline characteristics of all screened patients with newly diagnosed hypertension

VariableAll patients with available data, n/n PA negative/PA positivePA negativePA positiveP-value
Demographics
  Sex (male), n (%)334/9173 (51.8)4 (44.4)0.744
  Age, years, mean (SD)334/953.4 (11.2)54.3 (9.2)0.763
  BMI, kg/m2, n (%)213/90.498
    ≤2547 (22.1)1 (11.1)
    >25–≤3096 (45.1)6 (66.7)
    >3070 (32.9)2 (22.2)
  Smoking status, n (%)163/90.404
    Current36 (22.1)2 (22.2)
    Former55 (33.7)1 (11.1)
    Never72 (44.2)6 (66.7)
Blood pressure, mean (SD)
  Systolic BP, mmHg332/9163.8 (13.4)158.6 (10.2)0.174
  Diastolic BP, mmHg329/996.3 (9.9)95.3 (9.1)0.747
  ABPM, mmHg47/2154.2 (15.7)166.5 (9.2)0.282
  ABPMday, mmHg42/1159.3 (15.6)161.0 (−)
  Home BP, mmHg2/0160.0 (0)
  Heart rate, beats/minute192/775.2 (12.6)68.6 (12.8)0.224
Biochemical parameters
  Serum potassium, mmol/l, mean (SD)332/94.43 (0.33)4.11 (0.26)0.006
  Serum sodium, mmol/l, mean (SD)332/9141.7 (2.0)141.7 (2.6)0.951
  Serum creatinine, µmol/l, mean (SD)332/978.8 (14.6)75.8 (13.1)0.510
  Plasma aldosterone, pmol/l, mean (SD)334/9360.9 (220.5)668.4 (118.1)<0.001
  Renin, pmol/l, median (IQR)334/90.78 (0.58 to 1.33)0.48 (0.34 to 0.68)0.003
  ARR, pmol/mU, mean (SD)334/929.8 (22.8)105.3 (48.6)0.002
  Serum glucose, mmol/l, mean (SD)301/95.4 (1.0)5.4 (0.5)0.750
Cardiovascular morbidity, n (%)
  OSAS334/95 (1.5)01.000
  Atrial fibrillation334/92 (0.6)01.000
  Stroke334/92 (0.6)01.000
  Myocardial infarction334/92 (0.6)01.000
  • ABPM = ambulatory blood pressure monitoring. ARR = aldosterone-to-renin ratio. BMI = body mass index. Home BP = home systolic blood pressure. IQR = interquartile range. OSAS = obstructive sleep apnoea syndrome. PA = primary aldosteronism. SD = standard deviation.